Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Capital

September 2, 2022

Abivax : financement de 49,2 millions d’euros

CFNEWS

September 2, 2022

Abivax se tourne vers les Etats-Unis

Les Echos investir

September 2, 2022

Abivax lève près de 50 millions d’euros de nouveaux financements

BIOCENTURY

September 2, 2022

Updates from Abivax

LABIOTECH

September 2, 2022

Abivax pulls in €49.2M but needs more to complete ulcerative colitis program

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn